Sökning: onr:"swepub:oai:DiVA.org:uu-212990" > A Neonatal Amikacin...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03052naa a2200361 4500 | |
001 | oai:DiVA.org:uu-212990 | |
003 | SwePub | |
008 | 131217s2014 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-2129902 URI |
024 | 7 | a https://doi.org/10.1007/s11095-013-1197-y2 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a De Cock, Roosmarijn F W4 aut |
245 | 1 0 | a A Neonatal Amikacin Covariate Model Can Be Used to Predict Ontogeny of Other Drugs Eliminated Through Glomerular Filtration in Neonates |
264 | c 2013-09-25 | |
264 | 1 | b Springer Science and Business Media LLC,c 2014 |
338 | a print2 rdacarrier | |
520 | a PURPOSERecently, a covariate model characterizing developmental changes in clearance of amikacin in neonates has been developed using birth bodyweight and postnatal age. The aim of this study was to evaluate whether this covariate model can be used to predict maturation in clearance of other renally excreted drugs.METHODSFive different neonatal datasets were available on netilmicin, vancomycin, tobramycin and gentamicin. The extensively validated covariate model for amikacin clearance was used to predict clearance of these drugs. In addition, independent reference models were developed based on a systematic covariate analysis.RESULTSThe descriptive and predictive properties of the models developed using the amikacin covariate model were good, and fairly similar to the independent reference models (goodness-of-fit plots, NPDE). Moreover, similar clearance values were obtained for both approaches. Finally, the same covariates as in the covariate model of amikacin, i.e. birth bodyweight and postnatal age, were identified on clearance in the independent reference models.CONCLUSIONSThis study shows that pediatric covariate models may contain physiological information since information derived from one drug can be used to describe other drugs. This semi-physiological approach may be used to optimize sparse data analysis and to derive individualized dosing algorithms for drugs in children. | |
700 | 1 | a Allegaert, Karel4 aut |
700 | 1 | a Sherwin, Catherine M T4 aut |
700 | 1 | a Nielsen, Elisabet Iu Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Farmakometri4 aut0 (Swepub:uu)elnie838 |
700 | 1 | a de Hoog, Matthijs4 aut |
700 | 1 | a van den Anker, Johannes N4 aut |
700 | 1 | a Danhof, Meindert4 aut |
700 | 1 | a Knibbe, Catherijne A J4 aut |
710 | 2 | a Uppsala universitetb Institutionen för farmaceutisk biovetenskap4 org |
773 | 0 | t Pharmaceutical researchd : Springer Science and Business Media LLCg 31:3, s. 754-767q 31:3<754-767x 0724-8741x 1573-904X |
856 | 4 | u https://lirias.kuleuven.be/bitstream/123456789/624215/2/Pharm%20Res%202014%20covariate%20model%20AG%20neonates.pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-212990 |
856 | 4 8 | u https://doi.org/10.1007/s11095-013-1197-y |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.